Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:losartan
|
| gptkbp:approvalYear |
1995
|
| gptkbp:ATCCode |
C09CA01
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to losartan |
| gptkbp:drugClass |
angiotensin II receptor blocker
|
| gptkbp:eliminatedIn |
urine
bile |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericAvailable |
yes
|
| gptkbp:halfLife |
2 hours (losartan), 6-9 hours (active metabolite)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cozaar
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
back pain upper respiratory infection |
| gptkbp:usedFor |
hypertension
diabetic nephropathy stroke risk reduction |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|